Emcure Pharma lists at a 31% premium to its issue price of ₹1,008. The company's Rs 1,952 crore IPO was subscribed 67.8 times during the bidding period. Ekta Batra reports.
#emcure #emcurepharma #emcurepharmaceuticals #ipo #listing #ipolisting #nse #bse #ipolisting #newlisting #primarymarket #dalalstreet #stockmarkets #stockmarketnews #stockmarketupdates #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday
Read web story: [ Ссылка ]
🔴CNBC TV18 LIVE TV: [ Ссылка ]
SUBSCRIBE to our Channel: [ Ссылка ]
---------------------------------------------------------------------------------------------------------------------
👑 Check Out Top CNBC TV18 Playlist Videos:
🔹Lok Sabha Elections 2024: [ Ссылка ]
🔹CNBC TV18 Digital Podcast: [ Ссылка ]
🔹Sounding Board: [ Ссылка ]
🔹International Videos: [ Ссылка ]
🔹CNBC TV18 Market Cafe: [ Ссылка ]
🔹CNBC TV18 Digital: [ Ссылка ]
🔹CNBC TV18 Weekend Special: [ Ссылка ]
🔹CNBC TV18 Next-Gen: [ Ссылка ]
🔹Overdrive Show: [ Ссылка ]
🔹Young Turks: [ Ссылка ]
🔹Starup Streets: [ Ссылка ]
------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: [ Ссылка ]
Follow CNBC-TV18 round the clock: [ Ссылка ]
Stay updated with all the market action in real time: [ Ссылка ]
You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: [ Ссылка ]
Like us on Facebook: [ Ссылка ]
Follow us on Twitter: [ Ссылка ]
Follow us on Instagram: [ Ссылка ]
Catch us on: Linkedin: [ Ссылка ]
n18oc_business
About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.
